Surgery Partners (SGRY) Net Income towards Common Stockholders (2014 - 2026)
Surgery Partners (SGRY) posted Net Income towards Common Stockholders of -$2.1 million for Q1 2026, down 107.24% sequentially from $29.0 million in Q4 2025, and down 600.0% YoY from $420000.0 in Q1 2025.
Surgery Partners (SGRY) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends
Surgery Partners has reported Net Income towards Common Stockholders for 13 years, with the latest figure at -$2.1 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 600.0% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97.1 million (up 902.48% YoY) and the FY2025 annual result came in at $98.9 million, up 691.2% from the prior year.
- Net Income towards Common Stockholders declined to -$2.1 million in Q1 2026 per SGRY's latest filing, from $29.0 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $57.7 million in Q2 2023 and troughed at -$46.6 million in Q4 2024.
- A 5-year average of $11.2 million and a median of $12.2 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders plunged 23300.0% in 2022, then soared 1925.0% in 2024.
- Over 5 years, Net Income towards Common Stockholders stood at -$23.4 million in 2022, then surged by 299.57% to $46.7 million in 2023, then tumbled by 199.79% to -$46.6 million in 2024, then jumped by 162.23% to $29.0 million in 2025, then slumped by 107.24% to -$2.1 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$2.1 million, $29.0 million, and $25.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 1.93 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 826.00 Mn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | -600,000.00 |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 343.22 Mn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 99.83 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 358.45 Mn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 76.35 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 67.70 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 67.30 Mn |
| 10 | Surgery Partners | 1.97 Bn | 3.18 Bn | 622.10 Mn | 29.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.70 Mn |
| Mar 31, 2026 | -2.10 Mn |
| Dec 31, 2025 | 29.00 Mn |
| Sep 30, 2025 | 25.30 Mn |
| Jun 30, 2025 | 44.90 Mn |
| Mar 31, 2025 | -300,000.00 |
| Dec 31, 2024 | -46.60 Mn |
| Sep 30, 2024 | 6.40 Mn |
| Jun 30, 2024 | 28.40 Mn |
| Mar 31, 2024 | 24.30 Mn |
| Dec 31, 2023 | 46.70 Mn |
| Sep 30, 2023 | 29.70 Mn |
| Jun 30, 2023 | 57.70 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | -23.40 Mn |
| Sep 30, 2022 | -25.00 Mn |
| Jun 30, 2022 | -18.40 Mn |
| Mar 31, 2022 | 12.20 Mn |
| Dec 31, 2021 | -100,000.00 |
| Sep 30, 2021 | -22.90 Mn |